About ETIRARX, INC.
Etira is a biotechnology company focused on developing cutting-edge cancer treatments, particularly for metastatic cancers such as ovarian, breast, pancreatic, and glioblastoma. The company is working on investigational medicine ERX-315, aiming to provide new therapeutic options for patients with limited treatment options.
Development of investigational cancer therapiesResearch in smarter medicine for metastatic cancersClinical trials for advanced-stage cancer patients
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ETIRARX, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.